Vitalant FDA Inspection Record
Vitalant is an FDA-inspected facility (FEI 2971637) located in Sacramento, CA, US. RegDataLab tracks 8 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Oct 6, 2026: No Action Indicated (NAI)
- Inspections on record
- 8 (8 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 18, latest Sep 27, 2005
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Oct 6, 2026 | No Action Indicated (NAI) | No citations listed |
| Dec 13, 2023 | No Action Indicated (NAI) | No citations listed |
| Dec 20, 2018 | No Action Indicated (NAI) | No citations listed |
| Dec 2, 2016 | No Action Indicated (NAI) | No citations listed |
| Nov 5, 2014 | No Action Indicated (NAI) | No citations listed |
| Mar 18, 2013 | No Action Indicated (NAI) | No citations listed |
| Apr 26, 2011 | No Action Indicated (NAI) | No citations listed |
| Feb 11, 2009 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Sep 27, 2005 | Class III | B-1473-12 | Red Blood Cells Leukocytes Reduced Blood product, collected from a donor whose hematocrit was not recorded during donor screening, was distributed. |
| Feb 21, 2005 | Class III | B-1649-6 | Red Blood Cells, Leukocytes Reduced Blood product, for which the documentation of weld acceptability for the sterile docking of the filter was incorrect, was distributed. |
| Dec 23, 2004 | Class II | B-1541-08 | Platelets Pheresis Leukocytes Reduced and 1 more product Blood products, associated with a platelet unit that contained a clot, were distributed. |
| Dec 11, 2004 | Class II | B-1470-08 | Red Blood Cells Leukocytes Reduced Blood products, which tested negative for the Human Immunodeficiency Virus (HIV), but were collected from a donor who was previously… |
| Dec 11, 2004 | Class II | B-1584-08 | Red Blood Cells and 1 more product Blood products, which tested negative for the Human Immunodeficiency Virus (HIV), but were collected from a donor who was previously… |
| Nov 1, 2004 | Class II | B-1323-6 | Platelets Pheresis Leukocytes Reduced Irradiated Blood product, which was collected in a manner that may have compromised the sterility of the collection system, was distributed. |
| Oct 12, 2004 | Class III | B-1650-6 | Red Blood Cells, Leukocytes Reduced, Irradiated Blood products that were out of controlled storage for more than 30 minutes during irradiation, were distributed. |
| Mar 12, 2003 | Class II | B-1408-4 | Red Blood Cells, Leukocytes Reduced Blood product, collected in a manner that may have compromised the sterility of the unit, was distributed. |
| Jan 29, 2003 | Class II | B-1412-4 | Red Blood Cells Blood products, collected from ineligible donors due to decreased hematocrit values, were distributed. |
| Jan 9, 2003 | Class II | B-1817-4 | Red Blood Cells and 1 more product Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed. |
FDA record score
0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
9 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall B-1541-08, this FEI as the recalling firm | Dec 23, 2004 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1470-08, this FEI as the recalling firm | Dec 11, 2004 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1584-08, this FEI as the recalling firm | Dec 11, 2004 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1323-6, this FEI as the recalling firm | Nov 1, 2004 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1408-4, this FEI as the recalling firm | Mar 12, 2003 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1412-4, this FEI as the recalling firm | Jan 29, 2003 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1817-4, this FEI as the recalling firm | Jan 9, 2003 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1965-4, this FEI as the recalling firm | Sep 30, 2002 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0875-4, this FEI as the recalling firm | Apr 29, 2002 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Vitalant as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Vitalant yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Vitalant
- Location
- Sacramento, CA (US)
- Source
- inspections